Lysine in Combination With Estradiol Promote Dissemination of Estrogen Receptor Positive Breast Cancer via Upregulation of U2AF1 and RPN2 Proteins

The majority of estrogen receptor positive (ER+) breast cancer (BC) maintain the ER at metastatic sites. Despite anti-estrogen therapy, almost 30% of ER+ BC patients relapse. Thus, new therapeutic targets for ER+ BC are needed. Amino acids (AAs) may affect the metastatic capacity by affecting inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Vazquez Rodriguez, Gabriela, Abrahamsson, Annelie, Turkina, Maria V., Dabrosin, Charlotta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734348/
https://www.ncbi.nlm.nih.gov/pubmed/33330095
http://dx.doi.org/10.3389/fonc.2020.598684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734348/
https://www.ncbi.nlm.nih.gov/pubmed/33330095
http://dx.doi.org/10.3389/fonc.2020.598684

Ejemplares similares